MK-677 2mg — Vial Spec, Reconstitution Math & COA

Specification & Availability of MK-677 2mg Vials

In analytical chemistry and cell biology environments, the 2mg vial specification of MK-677 offers a controlled mass optimized for low-volume assay prep. Laboratories frequently deploy 2mg units when executing baseline dose-response experiments or micro-fluidic liquid handling protocols where high mass quantities are vulnerable to solubility decay or repeated thermal cycling.

PX1 Research manufactures and packages high-purity research compounds under strict GMP-compliant conditions within USA-based facilities. While analytical laboratories frequently request 2mg lyophilized unit fills for micro-scale testing, PX1 currently supplies MK-677 in specialized solid oral formats such as MK-677 Capsules 12.5mg alongside our broader catalog of lyophilized compounds in all peptides. If your specific research design strictly necessitates a 2mg vial mass or specialized solution format, contact our institutional support desk or browse our active inventory to select the precise mass configuration matching your laboratory's equipment requirements.

Mechanism of Action: Ghrelin Receptor Agonism in Preclinical Models

MK-677 (Ibutamoren mesylate) functions as a non-peptide, orally active growth hormone secretagogue that targets and selectively activates the growth hormone secretagogue receptor 1a (GHSR-1a), commonly referred to as the ghrelin receptor. In preclinical models, binding to GHSR-1a triggers a signaling cascade that stimulates the anterior pituitary gland to release growth hormone (GH) in a pulsatile manner.

In vitro and animal study data indicate that MK-677 activation of GHSR-1a results in a sustained elevation of circulating GH and insulin-like growth factor 1 (IGF-1) levels. Unlike direct administration of exogenous growth hormone, MK-677 maintains the natural endogenous pulsatility of GH release. Preclinical studies suggest that this continuous activation of the somatotrophic axis occurs without significantly increasing circulating cortisol, prolactin, or thyroid-stimulating hormone (TSH) levels, making it a valuable target for investigating ghrelin-mediated endocrine pathways.

Reconstitution Math for 2mg Lyophilized MK-677

Precise solubilization math is vital when translating a solid 2mg lyophilized mass into liquid working solutions for micro-pipetting. Adding varying volumes of lab-grade diluents directly alters the final mass concentration per microliter (μL) or milliliter (mL). Researchers must verify calculations before introducing liquid to maintaining exact target concentrations across assay plates.

When reconstituting a 2mg vial of MK-677, the following volumetric math applies depending on the volume of diluent added:

• 1.0 mL Diluent Addition: 2.0 mg / 1.0 mL = 2.0 mg/mL concentration (equivalent to 2.0 μg per 1.0 μL of solution). • 2.0 mL Diluent Addition: 2.0 mg / 2.0 mL = 1.0 mg/mL concentration (equivalent to 1.0 μg per 1.0 μL of solution). • 3.0 mL Diluent Addition: 2.0 mg / 3.0 mL = 0.667 mg/mL concentration (equivalent to 0.667 μg per 1.0 μL of solution).

To quickly model custom concentrations, volumetric shifts, or specific micro-liter delivery requirements across various vial masses, researchers should utilize the interactive PX1 reconstitution calculator to eliminate manual rounding errors prior to liquid handling.

Aliquot Planning and Liquid Handling in Micro-Scale Assays

Repeated freeze-thaw cycles present a primary mechanism for chemical degradation in peptide and small-molecule research solutions. When working with a reconstituted 2mg MK-677 solution, laboratories should establish an immediate aliquot protocol upon initial solubilization to protect compound integrity.

Following full dissolution, the primary stock solution should be transferred into sterile, polypropylene micro-centrifuge tubes pre-calibrated to the volume required for a single experimental run (e.g., 50 μL or 100 μL aliquots). Fast-freezing these single-use micro-tubes prevents the formation of large solvent crystals and ensures that the main stock is not exposed to thermal fluctuation, ambient moisture, or repeated ambient air contact during subsequent pipetting procedures.

Storage, Solubilization, and Chemical Stability Protocols

Lyophilized MK-677 in its dry, sealed glass vial state demonstrates excellent thermodynamic stability. Lyophilized vials should be stored in a dry, dark environment between -20°C and 4°C, shielded from direct ultraviolet (UV) light exposure. Under these conditions, the un-reconstituted powder maintains its defined structural purity across extended shelf periods.

MK-677 is a synthetic, non-peptide organic molecule that exhibits distinct solubility profiles compared to typical short-chain amino acid chains. While it dissolves readily in laboratory solvents such as dimethyl sulfoxide (DMSO) or ethanol for cell assay pre-mixes, aqueous reconstitution using sterile bacteriostatic water or standard phosphate-buffered saline (PBS) is standard for short-term bench top work. Once reconstituted into liquid form, the solution must be stored strictly at 2°C to 8°C and utilized within 14 to 30 days to prevent hydrolytic degradation or compound fallout.

Quality Assurance: HPLC, MS, and Lot-Matched COA Standards

Analytical precision in preclinical research requires uncompromising chemical purity. PX1 Research subjects every production lot to comprehensive verification by independent ISO 17025 accredited testing laboratories located within the United States. Compounds undergo high-performance liquid chromatography (HPLC) to verify chemical purity standards exceeding 99.0%, alongside Mass Spectrometry (MS) to confirm exact molecular weight and structural identity.

Furthermore, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) assay testing to verify that bacterial endotoxin levels remain strictly below rigorous international research limits (<0.01 EU/mg). Researchers can instantly access, verify, and download batch-specific documentation matching their exact lot number via the PX1 COA search portal, ensuring complete transparency and compliance for laboratory audits.

Comparative Secretagogue Profiling in Preclinical Research

Evaluating growth hormone secretagogues in vitro requires understanding structural and mechanical differences across compound classes. MK-677 differs fundamentally from traditional peptide-based GH secretagogues due to its non-peptide chemical structure, high oral stability, and extended terminal elimination half-life (approximately 24 hours in preclinical models).

When designing comparative secretagogue arrays, researchers often evaluate MK-677 alongside peptide compounds targeting the same or complementary endocrine axes:

• Ipamorelin: A selective, short-acting peptide secretagogue that binds GHSR-1a without inducing appetite stimulation or cortisol spikes. • CJC-1295: A synthetic GHRH analog designed to bind the GHRH receptor and extend growth hormone release via plasma protein affinity. • GHRP-6: An early-generation hexapeptide ghrelin agonist used to evaluate acute, high-amplitude GH release dynamics.

Unlike short-chain peptide secretagogues that require rapid enzymatic handling due to short plasma half-lives, MK-677 provides sustained, long-duration GHSR-1a receptor occupancy in experimental models.

Evaluating Scale Requirements: Transitioning from 2mg Vials

While a 2mg vial mass is optimal for initial feasibility studies, analytical screening, or single-plate cell assays, high-throughput animal study models or long-term longitudinal protocols demand larger supply capacities to maintain protocol continuity and minimize batch-to-batch variable shifts.

Laboratories expanding their research scope can review our comprehensive research catalog or establish institutional ordering pathways through the PX1 wholesale portal. Transitioning to larger lot sizes or secondary delivery formats helps research facilities streamline liquid handling logistics, reduce per-milligram operational overhead, and maintain uniform compound consistency across long-duration experimental timelines.

Laboratory Safety and Chemical Handling Guidelines

MK-677 is a potent, non-peptide bio-active chemical agent manufactured strictly for laboratory research use only. It is explicitly not intended for human consumption, veterinary application, clinical administration, or therapeutic diagnostic use. All handling must occur within certified laboratory settings equipped with proper personal protective equipment (PPE), including nitrile gloves, lab coats, and safety eyewear.

Handling personnel must utilize chemical fume hoods or laminar flow cabinets during powder manipulation or reconstitution to prevent accidental inhalation or skin exposure. Complete safety data sheets (SDS) and technical safety parameters for all GH secretagogues are maintained within the PX1 research library for facility safety officers and primary investigators.